A Stock Analysis: Buy, Sell, or Hold?
A - Agilent Technologies Inc.
$112.61
2.37 (2.15%)
▲
5d:
+0.53%
30d:
-7.23%
90d:
-18.63%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 27, 2026
Get Alerted When A Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: A trading at deep discount. Market pricing in -6.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: A trading at deep discount. Market pricing in -6.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$190.09
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$118.03
4.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: A is currently trading at $112.61, which is considered slightly low relative to its 30-day fair value range of $111.57 to $121.33. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.8) compared to its historical average (20.6). Remarkably, the market is currently pricing in an annual earnings decline of 6.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, A is in a strong downtrend. The price is currently testing key support at $109.90. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $163.19 (+48.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, A is in a strong downtrend. The price is currently testing key support at $109.90. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $163.19 (+48.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$111.57 -
$121.33
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 48.0% below Wall St target ($163.19)
Fair Price Analysis
30-Day Fair Range
$111.57 -
$121.33
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$109.90
Resistance Level
$116.40
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.78
Wall Street Target
$163.19
(+48.0%)
Revenue Growth (YoY)
7.0%
Earnings Growth (YoY)
-3.6%
Profit Margin
18.3%
Valuation Discount vs History
-6.6% cheaper
PE vs Historical
16.8 vs 20.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.6%
(market-implied from PE analysis)
1-Year Target
$102.96
(-7%)
2-Year Target
$96.17
(-13%)
3-Year Target
$89.82
(-19%)
3-Yr Target (if PE normalizes)
(PE: 17→21)
$110.28
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 10.1%)
$196.34
(+78%)
Base:
(SPY PE: 16.8, Growth: 10.1%)
$147.06
(+33%)
Bear:
(PE: 14.3, Growth: 10.1%)
$125.00
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 24.57 | Current EPS (TTM): $4.53
Bull Case
$177.30
(+58%)
Analyst growth 44.8%, PE expands to 27.0
Base Case
$161.18
(+44%)
Market implied 44.8%, PE stable at 24.6
Bear Case
$75.68
(-32%)
Severe decline -20.0%, PE contracts to 20.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.8 to 20.6
Stabilization Target:
$135.35
(+22.8%)
PE Expansion Potential:
+22.8%
Share & Embed Analysis
Last updated: March 30, 2026 12:08 PM ET
Data refreshes hourly during market hours. Next update: 1:08 PM
Data refreshes hourly during market hours. Next update: 1:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is A showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-01-29
Rodney Gonsalves
SELL
3000 shares
2025-11-26
Padraig Mcdonnell
SELL
911 shares
2025-11-18
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 58 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 60 HOLD |
Advanced A Option Strategies
Professional options setups generated by AI based on today's A price and gamma walls.
